Study of LY3016859 in Participants With Diabetic Nephropathy

Clinical trial NCT01774981 · COMPLETED

Trial details

NCT number: NCT01774981
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetic Nephropathy

Start date: 2013-03-01
Primary completion: 2015-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.